nefrólogo
Mostrar másnefrólogo
Cita con el médico | precio a consultar |
Nefrectomía | $21000 - $23000 |
Cita con el médico | precio a consultar |
Diálisis | $400 - $500 |
Nefrectomía | $10000 - $12000 |
2019 - Halen, İstanbul/İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Nefroloji Uzmanı
2018 - 2023, İstanbul/İstanbul/Türkiye
MEMORIAL ATAŞEHİR HASTANESİ
Nefroloji Uzmanı
2013 - 2018, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2011 - 2013, Batman/Batman/Türkiye
BATMAN DEVLET HASTANESİ
Nefroloji Uzmanı
2008 - 2011, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2007 - 2008, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR DEVLET HASTANESİ
Mecburi Hizmet
2001 - 2002, Artvin/Artvin/Türkiye
ARHAVİ DERECİK TOPLUM SAĞLIK MERKEZİ
Mecburi Hizmet
Mostrar más2019 - Halen, İstanbul/İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Nefroloji Uzmanı
2018 - 2023, İstanbul/İstanbul/Türkiye
MEMORIAL ATAŞEHİR HASTANESİ
Nefroloji Uzmanı
2013 - 2018, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2011 - 2013, Batman/Batman/Türkiye
BATMAN DEVLET HASTANESİ
Nefroloji Uzmanı
2008 - 2011, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2007 - 2008, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR DEVLET HASTANESİ
Mecburi Hizmet
2001 - 2002, Artvin/Artvin/Türkiye
ARHAVİ DERECİK TOPLUM SAĞLIK MERKEZİ
Mecburi Hizmet
Cita con el médico | precio a consultar |
Litotricia uretroscópica | $7500 |
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Mostrar másEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.